Artificial intelligence has created an unusual investing environment. Companies willing to spend hundreds of billions of ...

Oracle (NYSE:ORCL | ORCL Price Prediction) at $175 looks compelling on the data. The stock has been pulled into the broader ...

Wall Street has shrugged off Oracle's AI spending before. This time the company's own paperwork is doing the warning.

The cloud giant's record quarter came with a reminder of just how expensive its artificial intelligence build-out has become.

Operators, auditors, and SEC filings now question AI lab economics. Inside the lab losses, Karp's warning, and Oracle's ...

The spending has hit cash generation; trailing free cash flow is minus $24.7 billion, and analysts expect FCF to remain negative, about $3.5 billion, in the fiscal fourth quarter. As Oracle pivots to ...

Prices are rising, but the payoffs are not clear ...

ORCL’s aggressive AI capex plan boosts growth but pressures free cash flow and may generate returns below long‑run equity market expectations after inclusion of costs. Revenue should accelerate in the ...

On Wednesday, Oracle (NYSE:ORCL) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This transcript is ...

The market widely overreacted to Oracle's Q4 earnings, and this creates a buying opportunity for investors on Thursday, in my opinion: Oracle's cloud infrastructure business is on fire, and while ...

ORCL shares declined 4.61% even as Baystate Health expanded its technology partnership. Baystate Health will deploy Oracle Health solutions across its Massachusetts care facilities. The partnership ...